This marcus evans conference will foster scouting opportunities on global networks to target the right leads, integrate robust evaluation and prioritisation methodologies, as well as further develop the scalability and sustainability of selected projects. The event will be held on 28th-30th of November 2016 in Barcelona, Spain. The R&D Scouting in Pharma conference will provide practical case studies on scouting strategies and beyond, in order to select and evaluate research leads, accelerate the process to turn them into value and future projects.
Why join this marcus evans conference?
- Gain the best practices to connect and engage with external opportunities
- Develop scouting structure and techniques
- Implement and boost networks to enhance your projects
- Transform your business to integrate innovative projects
- Enhance internal capabilities to evaluate and prioritize external assets
- Develop techniques and methodologies to make your discovery sustainable
- Benefit from corporate venturing and entrepreneurship
Expert Speaker Panel includes:
- Kristof Van Emelen, Scientific Director - Partnership Integrator, Janssen
- Patrick Jimonet, External Opportunities in early Drug Discovery, Sanofi
- Christophe Cans, Director, Portfolio Management and Strategic Marketing, Inserm Transfert
- Julie Brady, Business Development Manager for Drug Discovery, Dundee University
- Duncan Holmes, European Head, Discovery Partnerships with Academia, GSK
- Mary Faris, Director, CTI West Coast and Australia, Pfizer
For further information, please contact Constandinos Vinall, ConstandinosV@marcusevanscy.com or visit the event website: https://goo.gl/3omkMy